Mindfulness-based stress reduction for menopausal symptoms after risk-reducing salpingo-oophorectomy (PURSUE study): a randomised controlled trial
- PMID: 30222235
- PMCID: PMC6587763
- DOI: 10.1111/1471-0528.15471
Mindfulness-based stress reduction for menopausal symptoms after risk-reducing salpingo-oophorectomy (PURSUE study): a randomised controlled trial
Abstract
Objective: To assess the short- and long-term effects of mindfulness-based stress reduction (MBSR) on the resulting quality of life, sexual functioning, and sexual distress after risk-reducing salpingo-oophorectomy (RRSO).
Design: Randomised controlled trial.
Setting: A specialised family cancer clinic of the university medical center Groningen.
Population: Sixty-six women carriers of the BRCA1/2 mutation who developed at least two moderate-to-severe menopausal symptoms after RRSO.
Methods: Women were randomised to an 8-week MBSR training programme or to care as usual (CAU).
Main outcome measures: Change in the Menopause-Specific Quality of Life Questionnaire (MENQOL), the Female Sexual Function Index, and the Female Sexual Distress Scale, administered from baseline at 3, 6, and 12 months. Linear mixed modelling was applied to compare the effect of MBSR with CAU over time.
Results: At 3 and 12 months, there were statistically significant improvements in the MENQOL for the MBSR group compared with the CAU group (both P = 0.04). At 3 months, the mean MENQOL scores were 3.5 (95% confidence interval, 95% CI 3.0-3.9) and 3.8 (95% CI 3.3-4.2) for the MBSR and CAU groups, respectively; at 12 months, the corresponding values were 3.6 (95% CI 3.1-4.0) and 3.9 (95% CI 3.5-4.4). No significant differences were found between the MBSR and CAU groups in the other scores.
Conclusion: Mindfulness-based stress reduction was effective at improving quality of life in the short- and long-term for patients with menopausal symptoms after RRSO; however, it was not associated with an improvement in sexual functioning or distress.
Tweetable abstract: Mindfulness improves menopause-related quality of life in women after risk-reducing salpingo-oophorectomy.
Keywords: BRCA1/2; menopausal symptoms; mindfulness; salpingo-oophorectomy; sexual functioning; surgical menopause.
© 2018 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists.
Figures


Similar articles
-
Effects of Hormonal Replacement Therapy and Mindfulness-Based Stress Reduction on Climacteric Symptoms Following Risk-Reducing Salpingo-Oophorectomy.Healthcare (Basel). 2024 Aug 13;12(16):1612. doi: 10.3390/healthcare12161612. Healthcare (Basel). 2024. PMID: 39201170 Free PMC article.
-
Interventions to improve psychosocial well-being in female BRCA-mutation carriers following risk-reducing surgery.Cochrane Database Syst Rev. 2019 Oct 9;10(10):CD012894. doi: 10.1002/14651858.CD012894.pub2. Cochrane Database Syst Rev. 2019. PMID: 31595976 Free PMC article. Review.
-
Sexual dysfunction and body image in BRCA mutation carriers before and after risk-reducing salpingo-oophorectomy: a cross-sectional study.J Sex Med. 2025 Jun 3;22(6):1062-1068. doi: 10.1093/jsxmed/qdaf078. J Sex Med. 2025. PMID: 40319345
-
Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial.JAMA Oncol. 2021 Aug 1;7(8):1203-1212. doi: 10.1001/jamaoncol.2021.1590. JAMA Oncol. 2021. PMID: 34081085 Free PMC article. Clinical Trial.
-
Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis.Am J Obstet Gynecol. 2023 Oct;229(4):388-409.e4. doi: 10.1016/j.ajog.2023.03.045. Epub 2023 Apr 12. Am J Obstet Gynecol. 2023. PMID: 37059410
Cited by
-
Complementary and Alternative Therapies for Genitourinary Syndrome of Menopause : An Evidence Map.Ann Intern Med. 2024 Oct;177(10):1389-1399. doi: 10.7326/ANNALS-24-00603. Epub 2024 Sep 10. Ann Intern Med. 2024. PMID: 39250808 Free PMC article. Review.
-
Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.BJOG. 2023 Nov;130(12):1437-1450. doi: 10.1111/1471-0528.17511. Epub 2023 May 2. BJOG. 2023. PMID: 37132126 Free PMC article.
-
Effects of Hormonal Replacement Therapy and Mindfulness-Based Stress Reduction on Climacteric Symptoms Following Risk-Reducing Salpingo-Oophorectomy.Healthcare (Basel). 2024 Aug 13;12(16):1612. doi: 10.3390/healthcare12161612. Healthcare (Basel). 2024. PMID: 39201170 Free PMC article.
-
Interventions to improve psychosocial well-being in female BRCA-mutation carriers following risk-reducing surgery.Cochrane Database Syst Rev. 2019 Oct 9;10(10):CD012894. doi: 10.1002/14651858.CD012894.pub2. Cochrane Database Syst Rev. 2019. PMID: 31595976 Free PMC article. Review.
References
-
- Chen X, Guo T, Li B. Influence of prophylactic oophorectomy on mood and sexual function in women of menopausal transition or postmenopausal period. Arch Gynecol Obstet 2013;288:1101–6. - PubMed
-
- van der Kolk DM, de Bock GH, Leegte BK, Schaapveld M, Mourits MJE, de Vries J, et al. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Res Treat 2010;124:643–51. - PubMed
-
- Brohet RM, Velthuizen ME, Hogervorst FBL, Meijers‐Heijboer HEJ, Seynaeve C, Collée MJ, et al. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. J Med Genet 2014;51:98–107. - PubMed
-
- Woodward ER, Sleightholme HV, Considine AM, Williamson S, McHugo JM, Cruger DG. Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high‐risk and population risk women is ineffective. BJOG 2007;114:1500–9. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous